
|Articles|November 1, 2012
LNG-IUS may have potential in endometrial cancer
Insertion of a levonorgestrel intrauterine system (LNG-IUS) can reverse abnormal endometrial cell growth, according to the results of a small study in high-risk patients, suggesting that the device may have potential in treatment of women with early-stage endometrial cancer who are not candidates for surgery.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
HRSA updates cervical cancer screening guidelines
2
Review finds no evidence linking prenatal paracetamol use to increased risk of autism, ADHD
3
Study: No independent diabetes risk linked to timing, type of menopause
4
LPCN 1154 for postpartum depression continues clinical process after safety review
5











